हिंदी में पढ़ें
Banking & Financial Services
Income Tax Calculator
Personal Loan Calculator
Car Loan Calculator
Home Loan Calculator
Price control, ad-hoc regulatory changes may hamper pharma
Sun, Sep 02, 2018
The Indian pharma market (IPM) stood at Rs 121,833 crore at the end of financial year 2018, growing at 6.3 per cent over the last 12 months period. This represents a significant slowdown from the historic 13-14 per cent CAGR trends (2010-2016).
Pfizer ends research for new Alzheimer''s, Parkinson's drugs
Mon, Jan 08, 2018
Pfizer is not making any changes to research and development funding for tanezumab, which is marketed as a treatment for joint pain from osteoarthritis, fibromyalgia treatment Lyrica, or its rare disease program.
Stocks to watch today: Reliance, L&T, PNB Housing
Mon, Nov 07, 2016
BSE Sensex closed at 27,274.15 points, down 0.57% on Friday November 4, 2016. While NSE Nifty lost 0.60% on the same day and closed at 8,433.75 points.
US drugmaker Pfizer abandons plan to split into two companies; stock falls nearly 2%
Mon, Sep 26, 2016
US drugmaker Pfizer Inc, which has been considering a split into two companies for more than two years, said on Monday it would not do so because the move would not create any shareholder value.
Pfizer completes sale of 4 products deal to Piramal Enterprises
Mon, Sep 26, 2016
Pfizer on Monday announced that it has completed its transaction deal for the sale of four products to Piramal Enterprises.
Asian stocks edge up, dollar dips as markets await Fed clues
Tue, Aug 23, 2016
Fed fund futures imply around a 24% chance of an easing in September, rising to around 50% by December.
Pfizer to buy Medivation for $14 billion
Mon, Aug 22, 2016
Pfizer Inc has agreed to buy Medivation Inc which is a biopharmaceutical company focused on developing and commercializing in the treatment for cancer. The merger will be for $81.50 a share in cash for a total enterprise value of approximately $14 billion.
Pfizer plans to bring more global drugs to India
Mon, Aug 15, 2016
"Except for a couple of CNS (central nervous system) products and one pain product, we are not really missing a major portfolio. We are looking at couple of global products, though they have gone all off LOE (loss of exclusivity) to reintroduce them into India, we are also looking at that aspect of this juncture," Pfizer India Managing Director S Sridhar told analysts.
Wall Street pulled down by tech, auto stocks
Tue, Aug 02, 2016
Wall Street fell on Tuesday, with the S&P 500 and the Nasdaq having their worst day in more than a month, following weak economic data and losses in technology and consumer discretionary stocks.
Pharmaceutical sector set for wave of mergers, acquisitions: Study
Mon, May 30, 2016
After its failure to acquire Allergan, Pfizer recently announced plans to buy Anacor Pharmaceuticals
Pfizer to buy Anacor Pharma in Rs 34,000 crore deal
Mon, May 16, 2016
Pfizer will pay $99.25 per share for Anacor.
Pfizer expected to bid for acquisition of US cancer drug company Medivation
Wed, May 04, 2016
Medivation has not yet decided whether it should engage with Pfizer in negotiations and is in discussions with its financial and legal advisers